SGK3 and cancer: Indeed, several reports have described the contribution of SGK1 and/or SGK3 to cancer progression [41], [49]–[54], and a recent report identified a subset of breast-cancer cell lines that are intrinsically resistant to Akt inhibition due to constitutive upregulation of SGK1 [54], [55].